The Potential for Deep Learning Technology in Clinical Trials
Journal of Clinical Studies
Rein Therapeutics and Qureight broaden life science collaboration
Business Weekly
How is deep learning imaging advancing drug discovery for fibrosis?
Drug Discovery World
The role of NHS Big Data and AI technology in unlocking the future of lung and heart disease treatment
pharmaphorum
Qureight and Remedy Cell to validate RC-0315 in Phase Ib trial for IPF
Clinical Trials Arena
Vicore Pharma to track lung fibrosis trial with Qureight's AI-powered imaging platform
FirstWord PHARMA
Qureight tech deployed in lung fibrosis clinical trial
Health Tech World
Qureight and Avalyn Launch Strategic Partnership in Progressive Pulmonary Fibrosis
Pharma Focus Europe
Qureight and Avalyn launch strategic partnership in pulmonary fibrosis
PharmaTimes Online
Unravelling the most complex disease challenges in history: How AI startups are changing drug discovery
Startups Magazine
8 Questions by Playfair
Medium
Sifted Series A announcement
Sifted
UKTN Pitching to investors
UK Tech News
Cambridge Angels 5 Questions
AstraZeneca adopts Qureight platform for IPF research
Cambridge Independent
Cambridge tech podcast
Cambridge tech podcast
Addressing inequalities in healthcare
Digital Health
Venturing forth Cambridge Judge Business School
University of Cambridge